This site is intended for Healthcare professionals only.

Latest Neurosciences News

  • FDA withdraws MS drug - DaclizumabDaclizumab carried a boxed warning regarding the risk for liver injury and other immune-mediated disorders. The European Medicines Agency recalled the
Read More News

Case Of the Day

Neurosciences Latest Guidelines

  • New European Guidelines for MSGuidelines on the use of disease-modifying therapies in multiple sclerosis have been released jointly by the European Committee for Research and Treat

From Other Dialogues